Directory
>
Kellye Daniels Ms Dabt
Kellye Daniels Ms Dabt
Vice President, Toxicology | Enanta Pharmaceuticals
Watertown, Massachusetts, United States
Kellye Daniels Ms Dabt
Summary
Kellye Daniels is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as the Vice President of Toxicology at Enanta Pharmaceuticals. With a Ph.D. in Neuroscience from the University of Florida, she has extensive experience in assay development, drug discovery, and toxicology. Kellye has held various leadership roles, overseeing complex nonclinical studies and regulatory submissions while managing cross-functional teams. Her career spans over two decades, with significant contributions to both scientific research and development services. Kellye is known for her strategic insights in toxicology and her ability to bridge the gap between science and business. She has worked with government and commercial clients, showcasing her versatility in both corporate and research environments. Her professional journey reflects a commitment to advancing biopharmaceutical innovation and improving patient outcomes.
Kellye Daniels Ms Dabt
Work Experience
Vice President, Toxicology at
Enanta Pharmaceuticals
January 2021 - Present
Director, Toxicology and Pathology Services at
Southern Research
August 2007 - February 2015
Director, Toxicogenomics at
Gene Logic
October 2003 - August 2007
Application Scientist at
Thermogenic Imaging
May 2002 - September 2003
Program Director, Client Services at
Phase 1 Molecular Toxicology
September 2001 - April 2002
Collaboration Manager at
Rosetta Inpharmatics
March 2001 - August 2001
Project Leader, Pharmacogenomics at
CuraGen Corporation
January 1998 - January 2000
Kellye Daniels Ms Dabt
Education
University of Florida College of Medicine, Ph.D.
January 1992 - January 1997
University of South Florida, M.S.
January 1990 - January 1994
Florida State University, B.S.
January 1985 - January 1990
Frequently Asked Questions about Kellye Daniels Ms Dabt
What is Kellye Daniels Ms Dabt email address?
Kellye Daniels Ms Dabt's primary email address is ********@enanta.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kellye Daniels Ms Dabt work for?
Kellye Daniels Ms Dabt is a Vice President, Toxicology at Enanta Pharmaceuticals, a company specializing in Commercial physical research.
Where Kellye Daniels Ms Dabt graduated from?
Kellye Daniels Ms Dabt holds a degree in Neuroscience from University of Florida College of Medicine.
How can I directly contact Kellye Daniels Ms Dabt?
To contact Kellye Daniels Ms Dabt directly, you can use the email address ********@enanta.com. Complete contact information is available upon registration with Muraena.
Who is Kellye Daniels Ms Dabt?
Kellye Daniels is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as the Vice President of Toxicology at Enanta Pharmaceuticals. With a Ph.D. in Neuroscience from the University of Florida, she has extensive experience in assay development, drug discovery, and toxicology. Kellye has held various leadership roles, overseeing complex nonclinical studies and regulatory submissions while managing cross-functional teams. Her career spans over two decades, with significant contributions to both scientific research and development services. Kellye is known for her strategic insights in toxicology and her ability to bridge the gap between science and business. She has worked with government and commercial clients, showcasing her versatility in both corporate and research environments. Her professional journey reflects a commitment to advancing biopharmaceutical innovation and improving patient outcomes.
Kellye`s contact details
********@enanta.com
Colleagues
Vice President of Chemistry at Enanta Pharmaceuticals
Chief Financial Officer
Vice President, CMC
Chief Business Officer
Chief Product Strategy Officer
Vice President, DMPK & Bioanalysis
Chief Medical Officer
Executive Director, Contracts Administration
Executive Director of Accounting, Controller
Vice President of DMPK and Bioanalysis